Back to search
FDAFDA · Food and drugs·Recall number Z-0500-2020

BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only)

Published November 27, 2019 · Recall initiated: October 14, 2019

Summary

FDA records medical device Class II recall Z-0500-2020, published November 27, 2019 and initiated October 14, 2019. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 967,680; Lot: Lot Number: 9175971 UDI: 50382903065757. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
Distribution US Nationwide and Canada
Lot
Lot Number: 9175971 UDI: 50382903065757
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only) recalled?

Yes. FDA published recall Z-0500-2020 on November 27, 2019. Reported hazard: Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.

What should I do if I have this product?

Voluntary: Firm initiated · Letter